Second-line Chemotherapy and Its Survival Analysis of 181 Patients with
Extensive-stage Small Cell Lung Cancer in a Single Institute

Background and objective Small cell lung cancer (SCLC) is the most malignant neuroendocrine tumor and sensitive to chemotherapy and radiotherapy. However, most patients who receive first-line chemotherapy will relapse within one to two years. Once recurrent, it indicates poor prognosis. Currently, t...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Manjiao MA, Mengzhao WANG, Yan XU, Ke HU, Huihui LIU, Longyun LI, Wei ZHONG, Li ZHANG, Jing ZHAO, Huazhu WANG
Format:	Artigo
Sprache:	Chinês
Veröffentlicht:	Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2013-11-01
Schriftenreihe:	Chinese Journal of Lung Cancer
Schlagworte:	Extensive-stage small cell lung cancer Second-line chemotherapy Survival Prognostic factors
Online-Zugang:	http://dx.doi.org/10.3779/j.issn.1009-3419.2013.11.02
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!